PTGX
Protagonist Therapeutics Inc

3,359
Mkt Cap
$5.45B
Volume
706,162.00
52W High
$96.54
52W Low
$35.95
PE Ratio
137.51
PTGX Fundamentals
Price
$88.39
Prev Close
$87.10
Open
$87.50
50D MA
$84.73
Beta
0.45
Avg. Volume
870,278.30
EPS (Annual)
$4.23
P/B
8.43
Rev/Employee
$3.45M
$2,103.95
Loading...
Loading...

About

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
126

Frequently Asked Questions

What is Market Cap of Protagonist Therapeutics Inc?
What is the 52-week high for Protagonist Therapeutics Inc?
What is the 52-week low for Protagonist Therapeutics Inc?
What is Protagonist Therapeutics Inc stock price today?
What was Protagonist Therapeutics Inc stock price yesterday?
What is the PE ratio of Protagonist Therapeutics Inc?
What is the Price-to-Book ratio of Protagonist Therapeutics Inc?
What is the 50-day moving average of Protagonist Therapeutics Inc?
How many employees does Protagonist Therapeutics Inc have?

Latest PTGX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.